SAN DIEGO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Stride, Inc. (NYSE: LRN) securities between October 22, 2024 and October 28, 2025. Stride is a technology company that provides an education platform to deliver online learning to students throughout the U.S. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins ...

Core Viewpoint - aTyr Pharma, Inc. is facing a class action lawsuit due to allegations of misleading investors regarding the efficacy of its drug candidate, Efzofitimod, during a clinical trial for pulmonary sarcoidosis [1][3]. Company Overview - aTyr Pharma, Inc. is a clinical stage biotechnology company focused on developing therapies for fibrosis and inflammation through tRNA synthetase biology [1]. Legal Allegations - The lawsuit claims that aTyr's executives provided misleading information about the Phase 3 study of Efzofitimod, particularly regarding the forced taper approach and the drug's ability to reduce steroid usage in patients [3]. - On September 15, 2025, aTyr announced that the EFZO-FIT study did not meet its primary endpoint, leading to a significant drop in stock price from $6.03 to $1.02, an 83.2% decline in one day [4]. Next Steps - Shareholders interested in participating in the class action must submit their papers by December 8, 2025, to serve as lead plaintiff [5].

Core Viewpoint - WPP PLC is facing a class action lawsuit due to allegations of misleading investors about its business prospects and financial performance during the specified class period [1][3]. Summary by Sections Company Overview - WPP PLC is a global communications company that provides services in advertising, media management, consultancy, public relations, and branding [1]. Class Action Details - A class action was filed on behalf of investors who purchased WPP common stock between February 27, 2025, and July 8, 2025, alleging that the company misled them regarding its business outlook [1]. Allegations - The complaint claims that WPP created a false impression of having reliable information about its revenue outlook and growth potential while downplaying risks from seasonality and macroeconomic factors [3]. - It is alleged that WPP's optimistic reports on client acquisition and retention were not reflective of reality, as the company's media division was losing market share to competitors [3]. Impact of Trading Update - On July 9, 2025, WPP issued a trading update indicating a deterioration in performance, attributing this to macroeconomic uncertainties and weaker new business than expected, partly due to ongoing restructuring [4]. - Following this announcement, WPP's stock price fell from $35.82 to $29.34, a decline of approximately 18.1% [4]. Next Steps for Shareholders - Shareholders may be eligible to participate in the class action and can contact Robbins LLP if they wish to serve as lead plaintiffs [5].

Core Viewpoint - A class action lawsuit has been filed against Firefly Aerospace Inc. for allegedly misleading investors regarding its business prospects and operational readiness, particularly related to its IPO and subsequent financial disclosures [1][2]. Group 1: Allegations and Financial Impact - The complaint claims that the Offering Documents for the IPO were negligently prepared, failing to disclose overstated demand and growth prospects for Firefly's Spacecraft Solutions, as well as the operational readiness of its Alpha rocket program [2]. - Following disappointing financial results for Q2 2025, Firefly's stock price dropped by $7.58 per share (15.31%) to close at $41.94 on September 23, 2025 [3]. - After a significant operational setback with the Alpha Flight 7 rocket, the stock price fell further by $7.66 per share (20.73%) to close at $29.30 on September 30, 2025, indicating a substantial decline from the $45.00 per share IPO price [3]. Group 2: Legal Proceedings and Participation - Shareholders may be eligible to participate in the class action and can contact Robbins LLP if they wish to serve as lead plaintiffs, representing other class members in the litigation [4]. - Participation in the case is not required to be eligible for recovery, allowing shareholders to remain absent class members if they choose [4].

Core Viewpoint - Baxter International, Inc. is facing a class action lawsuit due to allegations of misleading investors about the safety of its Novum LVP device, which has been linked to serious malfunctions and risks to patient safety [1][3]. Allegations - The complaint states that Baxter failed to disclose systemic defects in the Novum LVP device, leading to malfunctions such as underinfusion, overinfusion, and non-delivery of fluids, which posed risks of serious injury or death to patients [3]. - Baxter was reportedly aware of multiple malfunctions, injuries, and deaths related to the device but did not take adequate remedial measures, leading to continued harm [3]. - The company’s statements regarding the safety, efficacy, and sales prospects of the Novum LVPs were claimed to be materially false and misleading [3]. Stock Impact - Following the announcement on July 31, 2025, regarding the suspension of all new Novum LVP sales, Baxter's stock price dropped by 22.4%, closing at $21.76 [4]. Next Steps for Shareholders - Shareholders interested in participating in the class action must submit their papers to the court by December 15, 2025, to serve as lead plaintiff [5]. - Shareholders can choose to remain absent class members without participating in the case [5]. Company Background - Baxter International, Inc. is a global company that develops, manufactures, and markets medical products used in healthcare facilities [1].

Core Points - A class action has been filed against Inspire Medical Systems, Inc. for allegedly misleading investors regarding the Inspire V device launch [1][2] - The Inspire V device is intended for treating obstructive sleep apnea and was marketed as a groundbreaking product [2] - The launch of Inspire V faced significant challenges, including poor demand and inadequate preparation by the company [3] Allegations - Inspire Medical Systems failed to complete essential tasks for the successful launch of Inspire V, such as training for treatment centers and updating IT systems [3] - The company did not ensure that Medicare reimbursement was in place at the time of the launch, which contributed to the launch's difficulties [3] Financial Impact - On August 4, 2025, Inspire revealed that the launch was facing an "elongated timeframe," leading to a drastic reduction in 2025 earnings guidance by over 80% [4] - Following this announcement, the stock price plummeted by $42.04 per share, a decline of more than 32%, resulting in a loss of $1.2 billion in market capitalization in one day [4] - From a high of $216.71 per share on September 23, 2024, the stock price dropped nearly 60%, erasing billions from the company's market capitalization [4]

Core Viewpoint - Robbins LLP has initiated a class action lawsuit on behalf of investors who acquired Fiserv, Inc. securities between July 23, 2025, and October 29, 2025, alleging that the company misled investors regarding its financial growth in 2025 [1][2]. Allegations - In July 2025, Fiserv revised its 2025 guidance, lowering its organic revenue growth expectations due to a review of new initiatives and products, which was described as a "re-underwriting" [2]. - The complaint claims that Fiserv's statements in July were false and misleading, as the company later admitted that its guidance was based on assumptions that were difficult to achieve [3]. Financial Impact - On October 29, 2025, Fiserv reported disappointing third-quarter results and acknowledged that its previous guidance was based on flawed assumptions, leading to a significant stock price drop of $55.57 per share, or 44%, from $126.17 to $70.60 [3]. Class Action Participation - Shareholders interested in serving as lead plaintiffs must submit their papers by January 5, 2026, but participation is not required to be eligible for recovery [4]. Company Background - Robbins LLP is recognized for its work in shareholder rights litigation, focusing on helping shareholders recover losses and improve corporate governance since 2002 [5].

SAN DIEGO, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Six Flags Entertainment Corporation (NYSE: FUN) common stock pursuant or traceable to the Company’s registration statement and prospectus issued in connection with the July 1, 2024 merger of Legacy Six Flags with Cedar Fair, L.P., and their subsidiaries and affiliates. Cedar Fair and Legacy Six Flags combined two amusement parks to create ...

Core Viewpoint - A class action lawsuit has been filed against Six Flags Entertainment Corporation (NYSE: FUN) on behalf of investors who acquired shares during the merger with Cedar Fair, alleging that the company misled investors regarding its financial health and operational needs prior to the merger [1][2]. Group 1: Merger Details - The merger between Legacy Six Flags and Cedar Fair was approved by shareholders on March 12, 2024, and closed on July 1, 2024, resulting in the creation of North America's largest regional amusement park operator with approximately 40 amusement parks and water parks [1][2]. - Following the merger, the newly formed entity changed its name to Six Flags and began trading under the ticker symbol "FUN" on the NYSE [2]. Group 2: Allegations Against Six Flags - The lawsuit alleges that Legacy Six Flags had significantly underinvested in its parks and operations, neglecting essential maintenance and improvements for several years before the merger [2]. - It is claimed that Legacy Six Flags required millions of dollars in undisclosed capital expenditures to maintain or grow its market share in the competitive amusement park industry [2]. - The complaint states that the financial projections presented to investors were unrealistic and not based on the actual conditions of the company at the time of the merger [2]. Group 3: Stock Performance - On the merger closing date, Six Flags stock was trading above $55 per share, but it subsequently plummeted to as low as $20 per share, marking a decline of nearly 64% [3].

Core Viewpoint - James Hardie Industries plc is facing a class action lawsuit for allegedly misleading investors about inventory destocking in its North America Fiber Cement segment, which led to a significant decline in sales and stock price [1][2][3]. Group 1: Allegations and Misleading Statements - The lawsuit claims that despite early signs of inventory destocking in April and May 2025, the company made false assurances to investors on May 20 and 21, 2025, about the strength of the segment and denied any destocking was occurring [2]. - The complaint highlights that the company engaged in practices resembling fraudulent channel stuffing, misrepresenting sales as driven by sustainable customer demand [2]. Group 2: Impact on Sales and Stock Price - On August 19, 2025, James Hardie disclosed a 12% decline in sales for the North America Fiber Cement segment due to customer destocking, which had been known to the company since April and May [3]. - Following this announcement, the company's stock price plummeted over 34%, dropping from $28.43 per share on August 18, 2025, to $18.64 per share on August 20, 2025 [3]. Group 3: Class Action Participation - Shareholders are informed that they may be eligible to participate in the class action against James Hardie Industries plc, with a deadline to submit papers to serve as lead plaintiff by December 23, 2025 [4]. - It is noted that shareholders do not need to participate in the case to be eligible for recovery, allowing them to remain as absent class members if they choose [4].